Inflammation plays a central pathogenic role in the initiation and progression of coronary atheroma and its clinical consequences. Cytokines are the mediators of cellular inflammation and promote local inflammation in the arterial wall, which may lead to vascular smooth muscle apoptosis, degradation of the fibrin cap and plaque rupture. Platelet adhesion and thrombus formation then occur, resulting clinically in unstable angina or myocardial infarction. Recent studies have suggested that cytokines are pathogenic, contributing directly to the disease process. 'Anti-cytokine' therapy may, therefore, be of benefit in preventing or slowing the progression of cardiovascular disease. Both oestrogens and testosterone have been shown to have immune-modulating effects; testosterone in particular appears to suppress activation of pro-inflammatory cytokines. Men with low testosterone levels are at increased risk of coronary artery disease. An anti-inflammatory effect of normal physiological levels of sex hormones may, therefore, be important in atheroprotection. In this Article, we discuss some of the mechanisms involved in atherosclerotic coronary artery disease and the putative link between testosterone deficiency and atheroma formation. We present the hypothesis that the immune-modulating properties of testosterone may be important in inhibiting atheroma formation and progression to acute coronary syndrome.

This article has been cited by other articles:

				P. Nantermet, S.-i. Harada, Y. Liu, S. Cheng, C. Johnson, Y. Yu, D. Kimme, D. Holder, P. Hodor, R. Phillips, et al. Gene Expression Analyses in Cynomolgus Monkeys Provides Mechanistic Insight into High-Density Lipoprotein-Cholesterol Reduction by Androgens in Primates Endocrinology, April 1, 2008; 149(4): 1551 - 1561. [Abstract] [Full Text] [PDF]

				A. D. Flouris, G. S. Metsios, A. Z. Jamurtas, and Y. Koutedakis Sexual dimorphism in the acute effects of secondhand smoke on thyroid hormone secretion, inflammatory markers and vascular function Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E456 - E462. [Abstract] [Full Text] [PDF]

				E. Debing, E. Peeters, W. Duquet, K. Poppe, B. Velkeniers, and P. Van den Brande Endogenous sex hormone levels in postmenopausal women undergoing carotid artery endarterectomy Eur. J. Endocrinol., June 1, 2007; 156(6): 687 - 693. [Abstract] [Full Text] [PDF]

				C. Foresta, N. Caretta, A. Lana, L. De Toni, A. Biagioli, A. Ferlin, and A. Garolla Reduced Number of Circulating Endothelial Progenitor Cells in Hypogonadal Men J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4599 - 4602. [Abstract] [Full Text] [PDF]

				J J Corrales, M Almeida, R Burgo, M T Mories, J M Miralles, and A Orfao Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency. J. Endocrinol., June 1, 2006; 189(3): 595 - 604. [Abstract] [Full Text] [PDF]

				K. J. Milne, D. B. Thorp, C. W. J. Melling, and E. G. Noble Castration inhibits exercise-induced accumulation of Hsp70 in male rodent hearts Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1610 - H1616. [Abstract] [Full Text] [PDF]

				G. D. Norata, G. Tibolla, P. M. Seccomandi, A. Poletti, and A. L. Catapano Dihydrotestosterone Decreases Tumor Necrosis Factor-{alpha} and Lipopolysaccharide-Induced Inflammatory Response in Human Endothelial Cells J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 546 - 554. [Abstract] [Full Text] [PDF]

				M Cutolo, A Sulli, and B Seriolo Estrogens, autoimmunity and the heart Lupus, September 1, 2005; 14(9): 675 - 678. [Abstract] [PDF]

				B. Galobardes, G. D. Smith, M. Jeffreys, S. Kinra, and P. McCarron Acne in Adolescence and Cause-specific Mortality: Lower Coronary Heart Disease but Higher Prostate Cancer Mortality: The Glasgow Alumni Cohort Study Am. J. Epidemiol., June 15, 2005; 161(12): 1094 - 1101. [Abstract] [Full Text] [PDF]

				E. S. Ford and S. Liu Invited Commentary: Acne in Adolescence--Protecting the Heart but Damaging the Prostate Later in Life? Am. J. Epidemiol., June 15, 2005; 161(12): 1102 - 1106. [Full Text] [PDF]

				J. Makinen, M. J. Jarvisalo, P. Pollanen, A. Perheentupa, K. Irjala, M. Koskenvuo, J. Makinen, I. Huhtaniemi, and O. T. Raitakari Increased Carotid Atherosclerosis in Andropausal Middle-Aged Men J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1603 - 1608. [Abstract] [Full Text] [PDF]

				S. Dhindsa, S. Prabhakar, M. Sethi, A. Bandyopadhyay, A. Chaudhuri, and P. Dandona Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5462 - 5468. [Abstract] [Full Text] [PDF]